one other would be NAN
can't say i'm totally convinced that there is a huge need for the technology (yet) but at the moment its market cap is roughly equivalent to how much cash it has in the bank - ie the market is attributing zero value to their technology and potential sales/deals
also it probably has the juciest of biotech charts of the moment looking to come off an established base around 20c
